

Care Step Pathways
This section provides stand-alone Care Step Pathways (CSPs) that have been customized for the Australian audience. We wish to thank Suzanne Bartlett, RN, Grad Cert(Can&Pall), MAdvNursPrac(NPRAC), of the Ballarat Regional Integrated Cancer Centre for thoughtful review of these materials.
List of CSPs
For Immunotherapy (Checkpoint Inhibitors):
Ipilimumab
Nivolumab
Pembrolizumab
Nivolumab/Ipilimumab
- Skin Toxicities – View Online
- Gastrointestinal Toxicities (Diarrhea and Colitis) – View Online
- Thyroiditis – View Online
- Hepatitis – View Online
- Hypophysitis – View Online
- Adrenal Insufficiency, primary – View Online
- Diabetes – View Online
- Pneumonitis – View Online
- Arthralgia/Arthritis – View Online
- Mucositis/Xerostomia – View Online
- Neuropathy – View Online
- Nephritis – View Online
For Intralesional Therapy:
Talimogene laherparepvec; T-VEC
- Overall Side Effects – View Online